Patents Represented by Attorney Richard J. Sterner
  • Patent number: 7462349
    Abstract: The invention is intended to adapt an already established clinical procedure for the treatment of multiple sclerosis (MS)—the use of beta interferon—to treat chronic human spinal cord injury. The present invention relates to the prevention of chronic inflammation and demyelination following spinal cord injury.
    Type: Grant
    Filed: October 24, 2003
    Date of Patent: December 9, 2008
    Inventor: Nurit Kalderon